FFRangio System Validation Study Commenced
FFRangio System Received CE Mark
FFRangio System Received US FDA 510(k) Market Clearance
FFRangio System Received Japan PMDA Approval
4th Generation FFRangio System Launched
FFRangio System Outcomes Study Presented And Published
Co-Promotion Agreement Announced
Ran Kornowski, MD, FESC
Ifat Lavi, PhD
Senior Leadership Team
Chief Executive Officer
Mr. Ramin Mousavi has executive leadership and operational experience in general management, marketing, strategy, product development, and commercialization across multiple market segments. Most recently, Mr. Mousavi led the patient monitoring and digital health portfolio at Baxter International. Prior to Baxter, he held various leadership assignments at Edwards Lifesciences. Mr. Mousavi served as CathWorks’s, Vice President of Global Marketing and Strategy and the Chief Marketing Officer from 2019 to 2020. Mr. Mousavi holds B.S. degrees in Computer and Electrical Engineering from University of California, Irvine. He also earned an M.B.A. from Paul Merage School of Business at UC Irvine, and received a Healthcare Executive Leadership certificate for Business Innovation in Global Healthcare from Harvard Business School.
Mr. Duraid Antone is a seasoned executive with over two decades of medical device industry experience. His expertise encompasses business development and growth, strategic and tactical planning, operations management, negotiations, and customer relationship management. Prior to CathWorks, Mr. Antone was the Founder and Chief Operating Officer for two medical device companies, BioStructures and Radius Medical, which were both acquired by major medical device companies. In addition, he served in the field of intelligence for the U.S. Army for almost ten years. Mr. Antone holds an M.B.A. from the University of Michigan, Ross School of Business and a B.A. in Management from National-Louis University in Evanston, IL.
Mica Mor BenDavid
Mrs. Mica Mor BenDavid joins CathWorks with over 13 years of finance, management, and operation experience in start-up companies, from seed to M&A, and as an audit manager at Ernst & Young. Mrs. Mor BenDavid is also a CPA.
She earned her B.A. in Business Administration, Management, and Operations from the College of Management- Academic Studies.
Mrs. Dalit Cohen-Shipperman joins CathWorks with over 14 years of executive positions in HR. She has led global cross organizational HR processes, supporting tactical and strategic growth objectives in a variety of company sizes and high-tech domains, such as telecom, commint, and network security. Mrs. Cohen-Shipperman earned her B.A. in Psychology and Communications from the Haifa University and her M.A. cum laude in Organizational Psychology from the Bar-Ilan University.
Mr. Mike Feher joins CathWorks with 15 years of leadership and operational experience, including financial planning and analysis, process improvement, resource allocation, and investor relations. Mr. Feher led strategic financial initiatives at Allied Universal, which targeted driving revenue, cutting costs, and penetrating international markets. He also held various leadership roles at Edwards Lifesciences in business finance, corporate strategy, and investor relations. Mike holds a B.S. degree in Accounting and Business Administration, with an emphasis in Finance and Economics, from Chapman University and is a licensed CPA. He also earned an M.B.A. in Corporate Finance from Marshall School of Business at the University of Southern California.
Dr Alex Froimovich
Dr. Alex Froimovich joins CathWorks with over 18 years of experience in the medical device industry. Dr. Froimovich has been integral to the development, commercialization, and evidence development of multiple lifesaving and life-changing innovative technologies globally, including the first drug-eluting stent, the market-leading transcatheter heart valve, and the most advanced deep brain stimulator. Dr. Froimovich brings a long track record in medical affairs and scientific communications successes at some of the leading medical device manufacturers such as Johnson & Johnson, Edwards Lifesciences, and Boston Scientific. He earned his M.D. from the Pontificia Universidad Católica de Chile and his M.B.A. from Rutgers Business School.
Mr. Asaf Jazcilevich is an experienced R&D manager with a solid track record of building and leading multi-disciplinary groups consisting of software, hardware, and algorithm engineers in various domains, such as mobile, display, and automotive. Mr. Jazcilevich joins CathWorks following a 12-year-long senior appointment in Samsung’s Israeli R&D Center, where he led the cutting-edge computer vision and image processing platforms – subsequently deployed in Samsung’s flagship products. Prior to Samsung, Mr. Jazcilevich served as a firmware team leader for TransChip and has also worked at Intel. Mr. Jazcilevich holds a B.Sc. in Electrical Engineering from the Tel-Aviv University.
Mrs. Sarita Monico joins CathWorks with two decades of medical device strategic marketing experience. Mrs. Monico was integral to the launch and commercialization of the revolutionary transcatheter aortic valve replacement therapy and multiple other lifesaving innovations. Most recently, Mrs. Monico led the U.S. commercial marketing efforts for the industry-leading electrophysiology portfolio at Johnson & Johnson. She earned her B.S. in Biochemistry and Cell Biology from UC San Diego.
Mr. Fabian Ngo joins CathWorks with 17 years of cross-functional experience, including market analytics, new product development, sales operations, and HR consulting. At Edwards Lifesciences, Mr. Ngo supported the launch of multiple generations of the transcatheter aortic valve replacement platform, established its first advanced analytics team on understanding clinician and patient dynamics, and was the commercial lead for the development of its next-generation monitoring platform. Mr. Ngo earned his B.A. in Economics from Claremont McKenna College and his M.B.A. with a specialization in Strategic Management and Marketing-Operations from the Wharton School of the University of Pennsylvania.
Ms. Ayelet Peer joins CathWorks with over 15 years of operational and executive quality and regulatory experience in both medical device and pharmaceutical companies. She has successfully led regulatory audits and served as the regulatory point of contact in communications and submissions to EU competent authorities, U.S. FDA, and Health Canada. Prior to CathWorks, Ms. Peer led the Quality and Regulatory Affairs in S.L.P., and has served for 8 years in various Quality and Regulatory Compliance positions in Teva. Ms. Peer earned her B.S. in Biology and Chemistry and her M.B.A with specialization in Entrepreneurship and Innovation Management, both from Tel-Aviv University.